Leap Therapeutics Inc (LPTX)
2.98
-0.02
(-0.50%)
USD |
NASDAQ |
Nov 14, 12:42
Leap Therapeutics Market Cap: 114.03M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 114.60M |
| November 12, 2024 | 124.36M |
| November 11, 2024 | 125.12M |
| November 08, 2024 | 123.98M |
| November 07, 2024 | 132.78M |
| November 06, 2024 | 141.96M |
| November 05, 2024 | 135.84M |
| November 04, 2024 | 140.43M |
| November 01, 2024 | 143.11M |
| October 31, 2024 | 143.11M |
| October 30, 2024 | 159.56M |
| October 29, 2024 | 176.40M |
| October 28, 2024 | 158.80M |
| October 25, 2024 | 137.75M |
| October 24, 2024 | 125.89M |
| October 23, 2024 | 117.09M |
| October 22, 2024 | 116.32M |
| October 21, 2024 | 114.03M |
| October 18, 2024 | 102.36M |
| October 17, 2024 | 89.16M |
| October 16, 2024 | 91.83M |
| October 15, 2024 | 87.63M |
| October 14, 2024 | 89.54M |
| October 11, 2024 | 88.39M |
| October 10, 2024 | 89.16M |
| Date | Value |
|---|---|
| October 09, 2024 | 90.30M |
| October 08, 2024 | 91.83M |
| October 07, 2024 | 91.07M |
| October 04, 2024 | 97.96M |
| October 03, 2024 | 94.51M |
| October 02, 2024 | 93.75M |
| October 01, 2024 | 92.22M |
| September 30, 2024 | 98.34M |
| September 27, 2024 | 103.31M |
| September 26, 2024 | 100.64M |
| September 25, 2024 | 99.87M |
| September 24, 2024 | 99.11M |
| September 23, 2024 | 103.70M |
| September 20, 2024 | 105.99M |
| September 19, 2024 | 108.67M |
| September 18, 2024 | 110.20M |
| September 17, 2024 | 107.14M |
| September 16, 2024 | 115.18M |
| September 13, 2024 | 104.84M |
| September 12, 2024 | 107.52M |
| September 11, 2024 | 105.99M |
| September 10, 2024 | 107.98M |
| September 09, 2024 | 107.91M |
| September 06, 2024 | 107.52M |
| September 05, 2024 | 111.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
15.17M
Minimum
Nov 14 2019
352.23M
Maximum
Sep 30 2021
101.29M
Average
93.19M
Median
Jan 09 2024
Market Cap Benchmarks
| AIM ImmunoTech Inc | 15.58M |
| Perspective Therapeutics Inc | 610.22M |
| Protalix BioTherapeutics Inc | 100.02M |
| Electromed Inc | 246.21M |
| Armata Pharmaceuticals Inc | 98.78M |
Market Cap Related Metrics
| PS Ratio | 59.69 |
| Price to Book Value | 1.733 |
| Price | 2.98 |
| Earnings Yield | -58.39% |